• Working in the present,
    thinking the future

  • Health, our greatest asset value

  • Pharmacovigilance

  • Patient Centricity

We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community

Our products

are mainly addressed to be used in hematologic, oncologic, urologic and neurologic pathologies as well as rare diseases

Products

Hematology
Oncology
Neurology
Urology
Rare diseases

News

New Product Launch NILTARA®nilotinib

16/10/2024

Bioprofarma Bagó is pleased to present the launch of the product NILTARA® nilotinib, for its Hematology Line. This new product has been approved by ANMAT for the treatment of: Adult and pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML), recently diagnosed, in chronic phase; Adult patients with Philadelphia chromosome-positive CML in chronic phase and accelerated phase, […]

Read note

New Product Lunch IMPILO®bexarotene

08/07/2024

Bioprofarma Bagó replaces TARGRETIN® with IMPILO®bexarotene.

Read note

(Español) Nuevo lanzamiento HUTUS® enzalutamida

03/06/2024

(Español) Nos complace presentarles nuestro nuevo producto HUTUS® enzalutamida para cáncer de próstata

Read note

Bioprofarma Bagó worldwide